Chief Investment Officer
Ben Regin has served as our Chief Investment Officer since January 2023, having previously served as our Vice President of Investments since January 2020, and having joined our company as Director of Investments and Finance in January 2017. Until December 2016, Mr. Regin held positions as Senior Associate, Investments from May 2015 to December 2016 and Senior Associate, Asset Management from April 2013 to May 2015 with BioMed Realty Trust, Inc. (formerly NYSE: BMR), a REIT specializing in acquiring, leasing, developing and managing laboratory and office space for the life science industry. Prior to BioMed Realty, he was a Senior Associate, Finance; Associate,Business Operations at Westcore Properties, a privately-held, industrial-focused real estate investment company, from November 2007 to March 2013 and a Senior Audit Associate at PricewaterhouseCoopers LLP from September 2004 to November 2007. Mr. Regin received his Masters of Accountancy and Financial Management and Bachelors of Accountancy from the University of San Diego.